Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 40.58
+0.50 (1.25%)
May 28, 2026, 9:30 AM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 14.75 billion as of May 27, 2026. Its market cap has decreased by -14.60% in one year.
Market Cap
14.75B
Enterprise Value
14.21B
Revenue
638.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.58
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 14.75B, an increase of 94.42%. That is a compound annual growth rate of 10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 14.75B | -23.29% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Metis TechBio | 19.90B |
| Duality Biotherapeutics | 19.59B |
| Keymed Biosciences | 17.82B |
| TransThera Sciences (Nanjing) | 16.41B |
| Zai Lab | 16.24B |
| Ascletis Pharma | 15.55B |
| Nanjing Leads Biolabs | 12.42B |
| CStone Pharmaceuticals | 12.39B |